# EDGAR Filing Document

**Accession Number:** 0001977548
**File Stem:** 0001085146-25-005460
**Filing Date:** 2025-8
**Character Count:** 10670
**Document Hash:** 3b9faea38aeb616ec8718d3587c92750
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005460.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001085146-25-005460

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250825

**EFFECTIVENESS DATE**: 20250825

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Checkpoint Capital L.P.
- **CENTRAL INDEX KEY:** 0001977548

**ORGANIZATION NAME:**
- **EIN:** 884375303
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23869
- **FILM NUMBER:** 251249543

**BUSINESS ADDRESS:**
- **STREET 1:** 611 WASHINGTON STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111
- **BUSINESS PHONE:** 914-355-0570

**MAIL ADDRESS:**
- **STREET 1:** 611 WASHINGTON STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001977548

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Checkpoint Capital L.P.

**Address:** 611 WASHINGTON STREET, SAN FRANCISCO, CA 94111

**Telephone number:** 914-355-0570

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23869

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 254900WE08ZDOCZ66Y20

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                    | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                              | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| RHYTHM PHARMACEUTICALS, INC.      | 76243J105 | 09/18/2024     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         616715 |                0 | FOR         |                                   616715 | FOR                         |  |
| ARGENX SE                         | 04016X101 | 05/27/2025     | Adoption of the remuneration policy.                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         124000 |                0 | FOR         |                                   124000 | FOR                         |  |
| RAPT THERAPEUTICS, INC.           | 75382E109 | 05/29/2025     | To approve, on an advisory basis the compensation of the Company's named executive officers.                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| RAPT THERAPEUTICS, INC.           | 75382E109 | 05/29/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| STOKE THERAPEUTICS, INC.          | 86150R107 | 06/03/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| STOKE THERAPEUTICS, INC.          | 86150R107 | 06/03/2025     | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| CORCEPT THERAPEUTICS INCORPORATED | 218352102 | 06/10/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         109376 |                0 | FOR         |                                   109376 | FOR                         |  |
| DISC MEDICINE, INC.               | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to our named executive officers                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | FOR         |                                    40000 | FOR                         |  |
| DISC MEDICINE, INC.               | 254604101 | 06/11/2025     | To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to our named executive officers                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | ONE YEAR    |                                    40000 | FOR                         |  |
| DISC MEDICINE, INC.               | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to our named executive officers                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| DISC MEDICINE, INC.               | 254604101 | 06/11/2025     | To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to our named executive officers                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| PROTAGONIST THERAPEUTICS, INC.    | 74366E102 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         267989 |                0 | FOR         |                                   267989 | FOR                         |  |
| RHYTHM PHARMACEUTICALS, INC.      | 76243J105 | 06/24/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1043775 |                0 | FOR         |                                  1043775 | FOR                         |  |
| KYMERA THERAPEUTICS INC.          | 501575104 | 06/25/2026     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| REVOLUTION MEDICINES INC.         | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say on Pay"). | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** Checkpoint Capital L.P.

**By (Signature):** Sam Huang

**By (Printed Signature):** Sam Huang

**By (Title):** Managing Partner

**Date:** 08/25/2025